The store will not work correctly when cookies are disabled.
2-benzyl-8-fluoro-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
ID: ALA4859070
Cas Number: 39876-42-1
PubChem CID: 4445525
Max Phase: Preclinical
Molecular Formula: C18H17FN2
Molecular Weight: 280.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Fc1ccc2[nH]c3c(c2c1)CN(Cc1ccccc1)CC3
Standard InChI: InChI=1S/C18H17FN2/c19-14-6-7-17-15(10-14)16-12-21(9-8-18(16)20-17)11-13-4-2-1-3-5-13/h1-7,10,20H,8-9,11-12H2
Standard InChI Key: QQDXGEMPVMCBOD-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
3.6345 -17.8285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9687 -17.3481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2233 -16.5718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6788 -15.9653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8797 -16.1338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6280 -16.9142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1741 -17.5174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0387 -16.5714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2885 -17.3458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0796 -17.5157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6266 -16.9142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3769 -16.1398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5801 -15.9670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9256 -15.5343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7244 -15.7068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9702 -16.4844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7682 -16.6571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3179 -16.0512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0640 -15.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2667 -15.1010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3328 -15.5266 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 9 1 0
8 3 1 0
2 1 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
5 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 280.35 | Molecular Weight (Monoisotopic): 280.1376 | AlogP: 3.87 | #Rotatable Bonds: 2 |
Polar Surface Area: 19.03 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.62 | CX LogP: 3.61 | CX LogD: 3.55 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.75 | Np Likeness Score: -1.46 |
References
1. Schwarthoff S, Tischer N, Sager H, Schätz B, Rohrbach MM, Raztsou I, Robaa D, Gaube F, Arndt HD, Winckler T.. (2021) Evaluation of γ-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors., 46 [PMID:34391122] [10.1016/j.bmc.2021.116355] |